Patents by Inventor Peter Snyder

Peter Snyder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240346243
    Abstract: An attention application, such as a web browser, includes a pipeline optimized for faster, more secure, and more private, viewing of hypermedia documents using a reader mode. The reader mode is “always on” in the sense that a classifier runs on every web page and every compatible page is rendered in the reader mode and not rendered in full, referred to as the bloat page. Significant time savings are gained by avoiding fetching and rendering the bloat page at all because the bloat page devours network bandwidth and computing resources. Avoiding loading the bloat page also avoids exposing the user to what are often abusive privacy infringements and security vulnerabilities from running executable code in the browser, while providing an uncluttered viewing experience of content that is actually of interest to the user.
    Type: Application
    Filed: April 9, 2024
    Publication date: October 17, 2024
    Inventors: Benjamin Livshits, Peter Snyder, Andrius Aucinas
  • Patent number: 11960834
    Abstract: An attention application, such as a web browser, includes a pipeline optimized for faster, more secure, and more private, viewing of hypermedia documents using a reader mode. The reader mode is “always on” in the sense that a classifier runs on every web page and every compatible page is rendered in the reader mode and not rendered in full, referred to as the bloat page. Significant time savings are gained by avoiding fetching and rendering the bloat page at all because the bloat page devours network bandwidth and computing resources. Avoiding loading the bloat page also avoids exposing the user to what are often abusive privacy infringements and security vulnerabilities from running executable code in the browser, while providing an uncluttered viewing experience of content that is actually of interest to the user.
    Type: Grant
    Filed: September 30, 2019
    Date of Patent: April 16, 2024
    Assignee: Brave Software, Inc.
    Inventors: Benjamin Livshits, Peter Snyder, Andrius Aucinas
  • Patent number: 11717481
    Abstract: This invention is directed to reduction of flake-like aggregation in nanoparticulate compositions. Also encompassed by the invention are compositions comprising a nanoparticulate active agent, at least one surface stabilizer and a flake-like aggregation reducing agent, such as a buffer and a sugar. The nanoparticulate active agent compositions comprise particles of the active agent having an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: December 3, 2021
    Date of Patent: August 8, 2023
    Assignee: ALKERMES PHARMA IRELAND LIMITED
    Inventors: Niels P. Ryde, Peter Snyder, Wei Liu, David M. Slifer
  • Publication number: 20220211626
    Abstract: This invention is directed to reduction of flake-like aggregation in nanoparticulate compositions. Also encompassed by the invention are compositions comprising a nanoparticulate active agent, at least one surface stabilizer and a flake-like aggregation reducing agent, such as a buffer and a sugar. The nanoparticulate active agent compositions comprise particles of the active agent having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: December 3, 2021
    Publication date: July 7, 2022
    Inventors: Niels P. Ryde, Peter Snyder, Wei Liu, David M. Slifer
  • Patent number: 11253478
    Abstract: This invention is directed to reduction of flake-like aggregation in nanoparticulate compositions. Also encompassed by the invention are compositions comprising a nanoparticulate active agent, at least one surface stabilizer and a flake-like aggregation reducing agent, such as a buffer and a sugar. The nanoparticulate active agent compositions comprise particles of the active agent having an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: February 22, 2022
    Assignee: Alkermes Pharma Ireland Limited
    Inventors: Niels P. Ryde, Peter Snyder, Wei Liu, David M. Slifer
  • Publication number: 20210097134
    Abstract: An attention application, such as a web browser, includes a pipeline optimized for faster, more secure, and more private, viewing of hypermedia documents using a reader mode. The reader mode is “always on” in the sense that a classifier runs on every web page and every compatible page is rendered in the reader mode and not rendered in full, referred to as the bloat page. Significant time savings are gained by avoiding fetching and rendering the bloat page at all because the bloat page devours network bandwidth and computing resources. Avoiding loading the bloat page also avoids exposing the user to what are often abusive privacy infringements and security vulnerabilities from running executable code in the browser, while providing an uncluttered viewing experience of content that is actually of interest to the user.
    Type: Application
    Filed: September 30, 2019
    Publication date: April 1, 2021
    Applicant: Brave Software, Inc.
    Inventors: Benjamin Livshits, Peter Snyder, Andrius Aucinas
  • Publication number: 20180250229
    Abstract: This invention is directed to reduction of flake-like aggregation in nanoparticulate compositions. Also encompassed by the invention are compositions comprising a nanoparticulate active agent, at least one surface stabilizer and a flake-like aggregation reducing agent, such as a buffer and a sugar. The nanoparticulate active agent compositions comprise particles of the active agent having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: May 4, 2018
    Publication date: September 6, 2018
    Applicant: Alkermes Pharma Ireland Limited
    Inventors: Niels P. Ryde, Peter Snyder, Wei Liu, David M. Slifer
  • Publication number: 20180162849
    Abstract: A crystalline form of 6-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzoxazole is provided which is useful in the treatment of infections caused by Picornaviridae such as human rhinovirus (HRV), and in particular the crystal form is an anhydrous crystalline free base form of 6-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzoxazole. In addition, a method of manufacturing the free base crystalline form is also provided, including a step of micronizing the compound particles, optionally using a wetting agent, as well as pharmaceutical compositions incorporating the free base crystalline form such as tablets or suspensions, and methods of therapeutic treatments using this form and pharmaceutical compositions thereof.
    Type: Application
    Filed: September 22, 2017
    Publication date: June 14, 2018
    Inventors: Edward LEE, David MCALLISTER, Andrew TRIGWELL, Robert Vincent TUOHY, III, Peter SNYDER, JR., Christa Leisa FRASSETTO
  • Patent number: 9974748
    Abstract: This invention is directed to reduction of flake-like aggregation in nanoparticulate compositions. Also encompassed by the invention are compositions comprising a nanoparticulate active agent, at least one surface stabilizer and a flake-like aggregation reducing agent, such as a buffer and a sugar. The nanoparticulate active agent compositions comprise particles of the active agent having an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: April 15, 2016
    Date of Patent: May 22, 2018
    Assignee: Alkermes Pharma Ireland Limited
    Inventors: Niels P. Ryde, Peter Snyder, Wei Liu, David M. Slifer
  • Patent number: 9974747
    Abstract: This invention is directed to reduction of flake-like aggregation in nanoparticulate compositions. Also encompassed by the invention are compositions comprising a nanoparticulate active agent, at least one surface stabilizer and a flake-like aggregation reducing agent, such as a buffer and a sugar. The nanoparticulate active agent compositions comprise particles of the active agent having an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: April 15, 2016
    Date of Patent: May 22, 2018
    Assignee: Alkermes Pharma Ireland Limited
    Inventors: Niels P. Ryde, Peter Snyder, Wei Liu, David M. Slifer
  • Patent number: 9974746
    Abstract: This invention is directed to reduction of flake-like aggregation in nanoparticulate compositions. Also encompassed by the invention are compositions comprising a nanoparticulate active agent, at least one surface stabilizer and a flake-like aggregation reducing agent, such as a buffer and a sugar. The nanoparticulate active agent compositions comprise particles of the active agent having an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: April 15, 2016
    Date of Patent: May 22, 2018
    Assignee: Alkermes Pharma Ireland Limited
    Inventors: Niels P. Ryde, Peter Snyder, Wei Liu, David M. Slifer
  • Patent number: 9802926
    Abstract: A crystalline form of 6-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzoxazole is provided which is useful in the treatment of infections caused by Picornaviridae such as human rhinovirus (HRV), and in particular the crystal form is an anhydrous crystalline free base form of 6-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzoxazole. In addition, a method of manufacturing the free base crystalline form is also provided, including a step of micronizing the compound particles, optionally using a wetting agent, as well as pharmaceutical compositions incorporating the free base crystalline form such as tablets or suspensions, and methods of therapeutic treatments using this form and pharmaceutical compositions thereof.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: October 31, 2017
    Assignee: AVIRAGEN THERAPEUTICS, INC.
    Inventors: Edward Lee, David McAllister, Andrew Trigwell, Robert Vincent Tuohy, III, Peter Snyder, Jr., Christa Leisa Frassetto
  • Patent number: 9693507
    Abstract: The hedger trimming carriage and apparatus is a frame that is designed to be mounted on a vehicle. The frame of the hedger trimming carriage and apparatus is designed to carry during operation a hedger that is used to trim bushes and shrubbery while the vehicle is in motion. The hedger trimming carriage and apparatus comprises a mounting frame, a first hedger apparatus, and as second hedger apparatus.
    Type: Grant
    Filed: October 27, 2015
    Date of Patent: July 4, 2017
    Inventor: Peter Snyder
  • Publication number: 20160228555
    Abstract: This invention is directed to reduction of flake-like aggregation in nanoparticulate compositions. Also encompassed by the invention are compositions comprising a nanoparticulate active agent, at least one surface stabilizer and a flake-like aggregation reducing agent, such as a buffer and a sugar. The nanoparticulate active agent compositions comprise particles of the active agent having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: April 15, 2016
    Publication date: August 11, 2016
    Applicant: Alkermes Pharma Ireland Limited
    Inventors: Niels P. Ryde, Peter Snyder, Wei Liu, David M. Slifer
  • Publication number: 20160228554
    Abstract: This invention is directed to reduction of flake-like aggregation in nanoparticulate compositions. Also encompassed by the invention are compositions comprising a nanoparticulate active agent, at least one surface stabilizer and a flake-like aggregation reducing agent, such as a buffer and a sugar. The nanoparticulate active agent compositions comprise particles of the active agent having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: April 15, 2016
    Publication date: August 11, 2016
    Applicant: Alkermes Pharma Ireland Limited
    Inventors: Niels P. Ryde, Peter Snyder, Wei Liu, David M. Slifer
  • Publication number: 20160228372
    Abstract: This invention is directed to reduction of flake-like aggregation in nanoparticulate compositions. Also encompassed by the invention are compositions comprising a nanoparticulate active agent, at least one surface stabilizer and a flake-like aggregation reducing agent, such as a buffer and a sugar. The nanoparticulate active agent compositions comprise particles of the active agent having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: April 15, 2016
    Publication date: August 11, 2016
    Inventors: Niels P. Ryde, Peter Snyder, Wei Liu, David M. Slifer
  • Publication number: 20160194310
    Abstract: A crystalline form of 6-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzoxazole is provided which is useful in the treatment of infections caused by Picornaviridae such as human rhinovirus (HRV), and in particular the crystal form is an anhydrous crystalline free base form of 6-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzoxazole. In addition, a method of manufacturing the free base crystalline form is also provided, including a step of micronizing the compound particles, optionally using a wetting agent, as well as pharmaceutical compositions incorporating the free base crystalline form such as tablets or suspensions, and methods of therapeutic treatments using this form and pharmaceutical compositions thereof.
    Type: Application
    Filed: June 19, 2015
    Publication date: July 7, 2016
    Inventors: Edward LEE, David MCALLISTER, Andrew TRIGWELL, Robert Vincent TUOHY, Peter SNYDER, JR., Christa Leisa FRASSETTO
  • Patent number: 9345665
    Abstract: This invention is directed to reduction of flake-like aggregation in nanoparticulate compositions. Also encompassed by the invention are compositions comprising a nanoparticulate active agent, at least one surface stabilizer and a flake-like aggregation reducing agent, such as a buffer and a sugar. The nanoparticulate active agent compositions comprise particles of the active agent having an effective average particle size of less than about 2000 nm.
    Type: Grant
    Filed: December 18, 2013
    Date of Patent: May 24, 2016
    Assignee: Alkermes Pharma Ireland Limited
    Inventors: Niels P. Ryde, Peter Snyder, Wei Liu, David M. Slifer
  • Publication number: 20140105984
    Abstract: This invention is directed to reduction of flake-like aggregation in nanoparticulate compositions. Also encompassed by the invention are compositions comprising a nanoparticulate active agent, at least one surface stabilizer and a flake-like aggregation reducing agent, such as a buffer and a sugar. The nanoparticulate active agent compositions comprise particles of the active agent having an effective average particle size of less than about 2000 nm.
    Type: Application
    Filed: December 18, 2013
    Publication date: April 17, 2014
    Applicant: Alkermes Pharma Ireland Limited
    Inventors: Niels P. Ryde, Peter Snyder, Wei Liu, David M. Slifer
  • Patent number: 8291063
    Abstract: A processing system includes control circuitry to control the processing system, a remote management module to enable remote management of the processing system via a network, and an agent to operate as an intermediary between the remote management module and the control circuitry. The agent and the remote management module are configured to cooperatively implement an abstraction layer through which the agent and the remote management module communicate.
    Type: Grant
    Filed: March 4, 2005
    Date of Patent: October 16, 2012
    Assignee: NetApp, Inc.
    Inventors: Thomas Holland, Mark W. Insley, Pradeep Kalra, Peter Snyder